Journal Mobile Options
Table of Contents
Vol. 28, No. 4-5, 2006
Issue release date: August 2006

Serum Biomarkers after Traumatic and Hypoxemic Brain Injuries: Insight into the Biochemical Response of the Pediatric Brain to Inflicted Brain Injury

Pardes Berger R. · Adelson P.D. · Richichi R. · Kochanek P.M.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Inflicted traumatic brain injury (iTBI) involves a combination of mechanical trauma and hypoxemia. Serum biomarker concentrations may provide objective information about their relative importance to the pathophysiology of iTBI. We compared the time course of neuron-specific enolase (NSE), S100B and myelin basic protein after pediatric hypoxic-ischemic brain injury, iTBI and noninflicted TBI (nTBI). The time to reach peak concentrations of all three biomarkers was shorter after nTBI. Initial and peak S100B, initial and peak myelin basic protein and peak NSE concentrations were no different between the three groups. Initial NSE concentration was highest after nTBI. These results suggest that the biochemical response of the brain to iTBI is distinct from the response to nTBI and shares temporal similarities with hypoxic-ischemic brain injury. This may have important implications for the treatment and prognosis of children with iTBI.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Adelson PD, Ragheb J, Kanev P, Brockmeyer D, Beers SR, Brown SD, Cassidy LD, Chang Y, Levin H (2005): Phase II clinical trial of moderate hypothermia after severe traumatic brain injury in children. Neurosurgery 56:740–754; discussion 740–754.
  2. Beers S, Berger R, Skold A, Adelson P (2004): Neurocognitive outcome and relationship to serum markers in infants and young children following inflicted vs noninflicted traumatic brain injury. Pediatr Res 55:70.
  3. Bell MJ, Kochanek PM, Heyes MP, Wisniewski SR, Sinz EH, Clark RS, Blight AR, Marion DW, Adelson PD (1999): Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med 27:493–497.
  4. Berger R, Adelson P, Dulani T, Pierce M, Cassidy L, Kochanek P (2005): Serum neuron-specific enolase, S100B and myelin basic protein concentrations after inflicted and non-inflicted traumatic brain injury in children. J Neurosurg Pediatr 103:61–68.
  5. Berger RP, Heyes MP, Wisniewski SR, Adelson PD, Thomas N, Kochanek PM (2004): Assessment of the macrophage marker quinolinic acid in cerebrospinal fluid after pediatric traumatic brain injury: insight into the timing and severity of injury in child abuse. J Neurotrauma 21:1123–1130.
  6. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM (2002): Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109:E31.
  7. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K (2002): Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557–563.
  8. Billmire ME, Myers PA (1985): Serious head injury in infants: accident or abuse? Pediatrics 75:340–342.
  9. Bittigau P, Sifringer M, Pohl D, Stadthaus D, Ishimaru M, Shimizu H, Shimizu H, Ikeda M, Lang D, Speer A, Olney JW, Ikonomidou C (1999): Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol 45:724–735.
  10. Buki A, Okonkwo DO, Wang KK, Povlishock JT (2000): Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 20:2825–2834.
  11. Carty H, Pierce A (2002): Non-accidental injury: a retrospective analysis of a large cohort. Eur Radiol 12:2919–2925.
  12. Cho DY, Wang YC, Chi CS (1995): Decompressive craniotomy for acute shaken/impact baby syndrome. Pediatr Neurosurg 23:192–198.
  13. Duhaime AC, Alario AJ, Lewander WJ, Schut L, Sutton LN, Seidl TS, Nudelman S, Budenz D, Hertle R, Tsiaras W, et al (1992): Head injury in very young children: mechanisms, injury types, and ophthalmologic findings in 100 hospitalized patients younger than 2 years of age. Pediatrics 90:179–185.
  14. Ewing-Cobbs L, Prasad M, Kramer L, Louis PT, Baumgartner J, Fletcher JM, Alpert B (2000): Acute neuroradiologic findings in young children with inflicted or noninflicted traumatic brain injury. Childs Nerv Syst 16:25–33; discussion 34.
  15. Fridriksson T, Kini N, Walsh-Kelly C, Hennes H (2000): Serum neuron-specific enolase as a predictor of intracranial lesions in children with head trauma: a pilot study. Acad Emerg Med 7:816–820.
  16. Geddes JF, Hackshaw AK, Vowles GH, Nickols CD, Whitwell HL (2001): Neuropathology of inflicted head injury in children. 1. Patterns of brain damage. Brain 124:1290–1298.
  17. Heindl UT, Laub MC (1996): Outcome of persistent vegetative state following hypoxic or traumatic brain injury in children and adolescents. Neuropediatrics 27:94–100.
  18. Hymel KP, Abshire TC, Luckey DW, Jenny C (1997): Coagulopathy in pediatric abusive head trauma. Pediatrics 99:371–375.
  19. Hypothermia after Cardiac Arrest Study Group (2002): Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346:549–556.
  20. Ingebrigtsen T, Romner B (2002): Biochemical serum markers of traumatic brain injury. J Trauma 52:798–808.
  21. Jenny C, Hymel KP, Ritzen A, Reinert SE, Hay TC (1999): Analysis of missed cases of abusive head trauma. JAMA 281:621–626.
  22. Johnson DL, Boal D, Baule R (1995): Role of apnea in nonaccidental head injury. Pediatr Neurosurg 23:305–310.
  23. Keenan HT, Runyan DK, Marshall SW, Nocera MA, Merten DF, Sinal SH (2003): A population-based study of inflicted traumatic brain injury in young children. JAMA 290:621–626.
  24. Keenan HT, Runyan DK, Nocera M (2006): Child outcomes and family characteristics 1 year after severe inflicted or noninflicted traumatic brain injury. Pediatrics 117:317–324.
  25. King WJ, MacKay M, Sirnick A (2003): Shaken baby syndrome in Canada: clinical characteristics and outcomes of hospital cases. CMAJ 168:155–159.
  26. Kochanek PM, Clark RS, Ruppel RA, Adelson PD, Bell MJ, Whalen MJ, Robertson CL, Satchell MA, Seidberg NA, Marion DW, Jenkins LW (2000): Biochemical, cellular, and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: lessons learned from the bedside. Pediatr Crit Care Med 1:4–19.
  27. Le Roux PD, Jardine DS, Kanev PM, Loeser JD (1991): Pediatric intracranial pressure monitoring in hypoxic and nonhypoxic brain injury. Childs Nerv Syst 7:34–39.
  28. Makaroff KL, Putnam FW (2003): Outcomes of infants and children with inflicted traumatic brain injury. Dev Med Child Neurol 45:497–502.
  29. Mukherjee A, Vogt RF, Linthicum DS (1985): Measurement of myelin basic protein by radioimmunoassay in closed head trauma, multiple sclerosis and other neurological diseases. Clin Biochem 18:304–307.
  30. Mussack T, Biberthaler P, Kanz KG, Wiedemann E, Gippner-Steppert C, Jochum M (2001): S-100b, sE-selectin, and sP-selectin for evaluation of hypoxic brain damage in patients after cardiopulmonary resuscitation: pilot study. World J Surg 25:539–543; discussion 544.
  31. Nagdyman N, Komen W, Ko HK, Muller C, Obladen M (2001): Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 49:502–506.
  32. Noseworthy TW, Anderson BJ, Noseworthy AF, Shustack A, Johnston RG, Petruk KC, McPherson TA (1985): Cerebrospinal fluid myelin basic protein as a prognostic marker in patients with head injury. Crit Care Med 13:743–746.
  33. Rao P, Carty H, Pierce A (1999): The acute reversal sign: comparison of medical and non-accidental injury patients. Clin Radiol 54:495–501.
  34. Rosen H, Rosengren L, Herlitz J, Blomstrand C (1998): Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 29:473–477.
  35. Rosen H, Sunnerhagen KS, Herlitz J, Blomstrand C, Rosengren L (2001): Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 49:183–191.
  36. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ (1996): Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 10:471–476.
  37. Rovlias A, Kotsou S (2004): Classification and regression tree for prediction of outcome after severe head injury using simple clinical and laboratory variables. J Neurotrauma 21:886–893.
  38. Runyan CW, Casteel C, Perkis D, Black C, Marshall SW, Johnson RM, Coyne-Beasley T, Waller AE, Viswanathan S (2005): Unintentional injuries in the home in the United States. 1. Mortality. Am J Prev Med 28:73–79.
  39. Satchell MA, Lai Y, Kochanek PM, Wisniewski SR, Fink EL, Siedberg NA, Berger RP, DeKosky ST, Adelson PD, Clark RS (2005): Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse. J Cereb Blood Flow Metab 25:919–927.
  40. Schnitzer PG, Ewigman BG (2005): Child injury deaths: comparing prevention information from two coding systems. J Pediatr Psychol 30:413–423.
  41. Schoerkhuber W, Kittler H, Sterz F, Behringer W, Holzer M, Frossard M, Spitzauer S, Laggner AN (1999): Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 30:1598–1603.
  42. Spack L, Gedeit R, Splaingard M, Havens PL (1997): Failure of aggressive therapy to alter outcome in pediatric near-drowning. Pediatr Emerg Care 13:98–102.
  43. Spinella PC, Dominguez T, Drott HR, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M (2003): S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 31:939–945.
  44. Starling SP, Holden JR, Jenny C (1995): Abusive head trauma: the relationship of perpetrators to their victims. Pediatrics 95:259–262.
  45. Starling SP, Patel S, Burke BL, Sirotnak AP, Stronks S, Rosquist P (2004): Analysis of perpetrator admissions to inflicted traumatic brain injury in children. Arch Pediatr Adolesc Med 158:454–458.
  46. Tekgul H, Yalaz M, Kutukculer N, Ozbek S, Kose T, Akisu M, Kultursay N, Gokben S (2004): Value of biochemical markers for outcome in term infants with asphyxia. Pediatr Neurol 31:326–332.
  47. Thomas DG, Hoyle NR, Seeldrayers P (1984): Myelin basic protein immunoreactivity in serum of neurosurgical patients. J Neurol Neurosurg Psychiatry 47:173–175.
  48. Thomas DG, Palfreyman JW, Ratcliffe JG (1978): Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury. Lancet i:113–115.

    External Resources

  49. Thorngren-Jerneck K, Alling C, Herbst A, Amer-Wahlin I, Marsal K (2004): S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 55:406–412.


Pay-per-View Options
Direct payment This item at the regular price: USD 9.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 8.00